Drug absorption is a critical process that determines the entry of a drug into the bloodstream and its subsequent distribution throughout the body. This intricate phenomenon primarily occurs in the gastrointestinal tract, where the drug must traverse various barriers before reaching systemic circulation. The first step involves dissolution, where the drug dissolves in the gastrointestinal fluids. Subsequently, the drug must pass through the epithelial cells lining the intestinal wall, a process known as absorption. Factors influencing drug absorption include the drug's physicochemical properties, such as solubility and lipophilicity. The route of administration also plays a pivotal role, with oral ingestion being the most common. The presence of food in the stomach, pH levels, and the integrity of the gastrointestinal mucosa further impact absorption. Once absorbed, drugs enter the portal circulation and undergo first-pass metabolism in the liver before reaching the systemic circulation. Variability in drug absorption among individuals can be influenced by genetic factors, age, and the presence of other medications. Understanding the complexities of drug absorption is crucial for optimizing therapeutic outcomes and minimizing potential adverse effects. Researchers continually explore innovative approaches to improve drug absorption and bioavailability.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico